| P50 | author | Nathan Keller | Q115761101 |
| | Ella Mendelson | Q60299300 |
| | Aharona Glatman-Freedman | Q60299396 |
| | Tamy Shohat | Q60299532 |
| | Galia Rahav | Q88798024 |
| P2093 | author name string | Michal Mandelboim | |
| | Hanna Sefty | |
| | Musa Hindiyeh | |
| | Nehemya Friedman | |
| | Rakefet Pando | |
| | Yaron Drori | |
| | John McCauley | |
| | Ilana Tal | |
| | Sharon Alexandra Beni | |
| P2860 | cites work | Bayesian phylogenetics with BEAUti and the BEAST 1.7 | Q24286945 |
| | Mapping the antigenic and genetic evolution of influenza virus | Q29617255 |
| | Relationships between A(H1N1)pdm09 influenza infection and infections with other respiratory viruses. | Q30360993 |
| | Influenza A H1N1 pandemic strain evolution--divergence and the potential for antigenic drift variants. | Q30360996 |
| | Immunodominance of antigenic site B over site A of hemagglutinin of recent H3N2 influenza viruses | Q30419865 |
| | Overexpression of the alpha-2,6-sialyltransferase in MDCK cells increases influenza virus sensitivity to neuraminidase inhibitors | Q30452892 |
| | Evaluation of a multiplex real-time reverse transcriptase PCR assay for detection and differentiation of influenza viruses A and B during the 2001-2002 influenza season in Israel | Q33825639 |
| | Population genetic processes affecting the mode of selective sweeps and effective population size in influenza virus H3N2. | Q36094044 |
| | Ineffectiveness of the 2014-2015 H3N2 influenza vaccine | Q36738780 |
| | Interim estimates of 2016/17 vaccine effectiveness against influenza A(H3N2), Canada, January 2017. | Q37652088 |
| | Early 2016/17 vaccine effectiveness estimates against influenza A(H3N2): I-MOVE multicentre case control studies at primary care and hospital levels in Europe | Q37660781 |
| | Combined effectiveness of prior and current season influenza vaccination in northern Spain: 2016/17 mid-season analysis | Q37660785 |
| | Emergence of a novel subclade of influenza A(H3N2) virus in London, December 2016 to January 2017. | Q37708541 |
| | Mid-season real-time estimates of seasonal influenza vaccine effectiveness in persons 65 years and older in register-based surveillance, Stockholm County, Sweden, and Finland, January 2017 | Q37708550 |
| | Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies | Q38803189 |
| | Interim Estimates of 2016-17 Seasonal Influenza Vaccine Effectiveness - United States, February 2017. | Q38957414 |
| | Predicting clinical severity based on substitutions near epitope A of influenza A/H3N2. | Q41136139 |
| | Assessing Antigenic Drift of Seasonal Influenza A(H3N2) and A(H1N1)pdm09 Viruses | Q41254048 |
| | Start of the 2014/15 influenza season in Europe: drifted influenza A(H3N2) viruses circulate as dominant subtype | Q41474328 |
| | Substitutions near the receptor binding site determine major antigenic change during influenza virus evolution | Q42253862 |
| | Recommended composition of influenza virus vaccines for use in the 2017 southern hemisphere influenza season | Q95551654 |
| P921 | main subject | Israel | Q801 |
| P304 | page(s) | 71-75 | |
| P577 | publication date | 2017-06-04 | |
| P1433 | published in | Journal of Clinical Virology | Q15759726 |
| P1476 | title | Genetic divergence of Influenza A(H3N2) amino acid substitutions mark the beginning of the 2016-2017 winter season in Israel | |
| P478 | volume | 93 | |